Camouflage™ Hemocompatible Inert Surface
Camouflage™ technology is a proprietary coating technology incorporating a synthetic polymer combined with a protein base layer. The coating technology is non-toxic and demonstrates excellent hydrophilic properties. It is designed to reduce clotting cascade and provides long term stability for use on a range of blood contacting medical devices. Camouflage™ is underpinned by solid Intellectual property (IP) to differentiate and to create value for our customers.
The Mechanism of Action involves coating the device with non-inflammatory proteins (red blood cells and blood components) The device surface is masked by the circulatory blood and reduces the body’s reaction to the foreign surface.
The natural hemocompatibility between Camouflage™ material composition and the blood cells allows optimum biocompatibility with minimal adverse reactions, enabling blood flow without clotting
Benefits Of Camouflage™
- Non- Pharmaceutical and Heparin Free
- Demonstrates excellent hemocompatibility
- Adheres to many substrates
- Facilitates priming of medical devices
- Ease of priming
- Improved safety and function of medical devices by reducing the risk for thrombus formation
- Lower’s inflammatory response
- Cost of manufacture is lower than heparin
- ETO sterilizable
- IP protected
- Faster regulatory pathway vs Heparin(medicinal)
- Ease of application & integration into existing manufacturing process
- Established end-end supply chain
- Durable surface suitable for long-term usage
- Total service offering (feasibility to commercialisation)
- No visual change to the device
Properties of Camouflage™
- Biocompatible
- Hydrophilic
- Non-toxic
- Ultra-thin coating (nanoscale)
- Water based
- Excellent in-In-Vitro hemocompatibility performance
- Biologically Inert
Product Applications
KOL Statement
Camouflage™ Hemocompatible Inert Surface
Camouflage™ technology is a proprietary coating technology incorporating a synthetic polymer combined with a protein base layer. The coating technology is non-toxic and demonstrates excellent hydrophilic properties. It is designed to reduce clotting cascade and provides long term stability for use on a range of blood contacting medical devices. Camouflage™ is underpinned by solid Intellectual property (IP) to differentiate and to create value for our customers.
The Mechanism of Action involves coating the device with non-inflammatory proteins (red blood cells and blood components) The device surface is masked by the circulatory blood and reduces the body’s reaction to the foreign surface.
The natural hemocompatibility between Camouflage™ material composition and the blood cells allows optimum biocompatibility with minimal adverse reactions, enabling blood flow without clotting
Benefits Of Camouflage™
- Non- Pharmaceutical and Heparin Free
- Demonstrates excellent hemocompatibility
- Adheres to many substrates
- Facilitates priming of medical devices
- Ease of priming
- Improved safety and function of medical devices by reducing the risk for thrombus formation
- Lower’s inflammatory response
- Cost of manufacture is lower than heparin
- ETO sterilizable
- IP protected
- Faster regulatory pathway vs Heparin(medicinal)
- Ease of application & integration into existing manufacturing process
- Established end-end supply chain
- Durable surface suitable for long-term usage
- Total service offering(feasibility to commercialisation)
- No visual change to the device
Properties of Camouflage™
- Biocompatible
- Hydrophilic
- Non-toxic
- Ultra-thin coating (nanoscale)
- Water based
- Excellent in-In-Vitro hemocompatibility performance
- Biologically Inert
Product Applications